How comorbidities affect the surgical treatment planning in elderly patients with head and neck cancer?

BACKGROUND. Head and neck cancer is the sixth leading cancer by incidence worldwide. Surgery and postoperative radiotherapy are the current standards in the treatment of head and neck cancer (HNC). Chemotherapy in combination with the listed methods is also used. However, the choice of a treatmen...

Full description

Bibliographic Details
Main Authors: Dorota Dziemiańczyk-Pakieła, Natalia Tołoczko-Iwaniuk, Małgorzata Malinowska-Zaprzałka, Beata Klaudia Nowaszewska, Marek Chwiedosik, Jan Borys, Katarzyna Wawrzyn, Ewa Sierko
Format: Article
Language:English
Published: Kazimierz Wielki University 2018-04-01
Series:Journal of Education, Health and Sport
Subjects:
Online Access:http://www.ojs.ukw.edu.pl/index.php/johs/article/view/5453
_version_ 1818536587599806464
author Dorota Dziemiańczyk-Pakieła
Natalia Tołoczko-Iwaniuk
Małgorzata Malinowska-Zaprzałka
Beata Klaudia Nowaszewska
Marek Chwiedosik
Jan Borys
Katarzyna Wawrzyn
Ewa Sierko
author_facet Dorota Dziemiańczyk-Pakieła
Natalia Tołoczko-Iwaniuk
Małgorzata Malinowska-Zaprzałka
Beata Klaudia Nowaszewska
Marek Chwiedosik
Jan Borys
Katarzyna Wawrzyn
Ewa Sierko
author_sort Dorota Dziemiańczyk-Pakieła
collection DOAJ
description BACKGROUND. Head and neck cancer is the sixth leading cancer by incidence worldwide. Surgery and postoperative radiotherapy are the current standards in the treatment of head and neck cancer (HNC). Chemotherapy in combination with the listed methods is also used. However, the choice of a treatment sequence may be different for individual patients. Can-cer patients are predominantly individuals aged 65 years and over, with a number of treat-ed or untreated concomitant diseases. Therefore, comorbidities play a very significant role in treatment planning in this group of patients. METHODS. The issue was explored in a retrospective study of medical records of 108 HNC patients hospitalized at the Department of Maxillofacial and Plastic Surgery, Medical Uni-versity of Bialystok. The study focused on patients older than 65 years old as they are most predisposed to co-existing diseases which can affect treatment planning. The data were analyzed by gender, age and presence of comorbidities as well as by lesion location, histo-pathology, cancer staging notation system (TNM), treatment methods. RESULTS. Out of all cancer patients older than 65 years old, 44 were female and 64 were male at the average age of 75 and 78 years, respectively. The oldest patients were 88 years old (female) and 90 years old (male). Comorbidities were found in 62% of cases – 66% of women and 59.4% of men. The most frequent comorbidities were: hypertension – 41%, alco-hol abuse – 17%, diabetes mellitus – 14%, hyperlipidemia – 9%, coronary heart disease – 6%, asthma – 4%, atrial fibrillation – 3% of patients. 97% of patients underwent surgery, but in 17 cases (16%) the treatment plan had to be altered due to the patients' general health. Only 3% of patients were disqualified from surgical treatment due to their general condition. CONCLUSIONS: The choice of a treatment method in HNC patients should always be individ-ualized. Comorbidities, in a severe, unregulated form may reduce treatment options or be a contraindication to standard therapy methods. Fortunately, in the majority of cases, the di-versity of available surgical treatment modalities enables the selection of the most appro-priate method for a particular patient on the basis of his/her general condition.
first_indexed 2024-12-11T18:39:52Z
format Article
id doaj.art-8f674b4578cf4c9d8ea5cfdbd0a013a6
institution Directory Open Access Journal
issn 2391-8306
language English
last_indexed 2024-12-11T18:39:52Z
publishDate 2018-04-01
publisher Kazimierz Wielki University
record_format Article
series Journal of Education, Health and Sport
spelling doaj.art-8f674b4578cf4c9d8ea5cfdbd0a013a62022-12-22T00:54:39ZengKazimierz Wielki UniversityJournal of Education, Health and Sport2391-83062018-04-0185223610.5281/zenodo.12371275060How comorbidities affect the surgical treatment planning in elderly patients with head and neck cancer?Dorota Dziemiańczyk-Pakieła0Natalia Tołoczko-Iwaniuk1Małgorzata Malinowska-Zaprzałka2Beata Klaudia Nowaszewska3Marek Chwiedosik4Jan Borys5Katarzyna Wawrzyn6Ewa Sierko7Medical University of BialystokMedical University of BialystokMedical University of BialystokMedical University of BialystokMedical University of BialystokMedical University of BialystokDentalBlueMedical University of BialystokBACKGROUND. Head and neck cancer is the sixth leading cancer by incidence worldwide. Surgery and postoperative radiotherapy are the current standards in the treatment of head and neck cancer (HNC). Chemotherapy in combination with the listed methods is also used. However, the choice of a treatment sequence may be different for individual patients. Can-cer patients are predominantly individuals aged 65 years and over, with a number of treat-ed or untreated concomitant diseases. Therefore, comorbidities play a very significant role in treatment planning in this group of patients. METHODS. The issue was explored in a retrospective study of medical records of 108 HNC patients hospitalized at the Department of Maxillofacial and Plastic Surgery, Medical Uni-versity of Bialystok. The study focused on patients older than 65 years old as they are most predisposed to co-existing diseases which can affect treatment planning. The data were analyzed by gender, age and presence of comorbidities as well as by lesion location, histo-pathology, cancer staging notation system (TNM), treatment methods. RESULTS. Out of all cancer patients older than 65 years old, 44 were female and 64 were male at the average age of 75 and 78 years, respectively. The oldest patients were 88 years old (female) and 90 years old (male). Comorbidities were found in 62% of cases – 66% of women and 59.4% of men. The most frequent comorbidities were: hypertension – 41%, alco-hol abuse – 17%, diabetes mellitus – 14%, hyperlipidemia – 9%, coronary heart disease – 6%, asthma – 4%, atrial fibrillation – 3% of patients. 97% of patients underwent surgery, but in 17 cases (16%) the treatment plan had to be altered due to the patients' general health. Only 3% of patients were disqualified from surgical treatment due to their general condition. CONCLUSIONS: The choice of a treatment method in HNC patients should always be individ-ualized. Comorbidities, in a severe, unregulated form may reduce treatment options or be a contraindication to standard therapy methods. Fortunately, in the majority of cases, the di-versity of available surgical treatment modalities enables the selection of the most appro-priate method for a particular patient on the basis of his/her general condition.http://www.ojs.ukw.edu.pl/index.php/johs/article/view/5453head and neck cancertreatmentcomorbidities
spellingShingle Dorota Dziemiańczyk-Pakieła
Natalia Tołoczko-Iwaniuk
Małgorzata Malinowska-Zaprzałka
Beata Klaudia Nowaszewska
Marek Chwiedosik
Jan Borys
Katarzyna Wawrzyn
Ewa Sierko
How comorbidities affect the surgical treatment planning in elderly patients with head and neck cancer?
Journal of Education, Health and Sport
head and neck cancer
treatment
comorbidities
title How comorbidities affect the surgical treatment planning in elderly patients with head and neck cancer?
title_full How comorbidities affect the surgical treatment planning in elderly patients with head and neck cancer?
title_fullStr How comorbidities affect the surgical treatment planning in elderly patients with head and neck cancer?
title_full_unstemmed How comorbidities affect the surgical treatment planning in elderly patients with head and neck cancer?
title_short How comorbidities affect the surgical treatment planning in elderly patients with head and neck cancer?
title_sort how comorbidities affect the surgical treatment planning in elderly patients with head and neck cancer
topic head and neck cancer
treatment
comorbidities
url http://www.ojs.ukw.edu.pl/index.php/johs/article/view/5453
work_keys_str_mv AT dorotadziemianczykpakieła howcomorbiditiesaffectthesurgicaltreatmentplanninginelderlypatientswithheadandneckcancer
AT nataliatołoczkoiwaniuk howcomorbiditiesaffectthesurgicaltreatmentplanninginelderlypatientswithheadandneckcancer
AT małgorzatamalinowskazaprzałka howcomorbiditiesaffectthesurgicaltreatmentplanninginelderlypatientswithheadandneckcancer
AT beataklaudianowaszewska howcomorbiditiesaffectthesurgicaltreatmentplanninginelderlypatientswithheadandneckcancer
AT marekchwiedosik howcomorbiditiesaffectthesurgicaltreatmentplanninginelderlypatientswithheadandneckcancer
AT janborys howcomorbiditiesaffectthesurgicaltreatmentplanninginelderlypatientswithheadandneckcancer
AT katarzynawawrzyn howcomorbiditiesaffectthesurgicaltreatmentplanninginelderlypatientswithheadandneckcancer
AT ewasierko howcomorbiditiesaffectthesurgicaltreatmentplanninginelderlypatientswithheadandneckcancer